SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Alfacell (ACEL) -- Ignore unavailable to you. Want to Upgrade?

To: Tom Scozzafava who wrote (1403)6/22/1998 12:37:00 PM
From: r. parker griff  Respond to of 1533
 
hello team onconase here is the scenario that we are now in

Data being analyzed late summer completion date the trials are now
only numbers and stats presentable in a proper from

from that time frame it will be taken to the FDA and hopefully acted upon in the affirmative
if you know of someone who has failed on Lillys drug an onconase study
is avaiable for them i think.

we have come a long long way



To: Tom Scozzafava who wrote (1403)6/23/1998 6:58:00 AM
From: Fish  Respond to of 1533
 
Tom - I'm glad we agree. It appears we approached this issue from two different perspectives.
Leighton - In the future you may wish to consider justifying your name calling by specific examples and concrete rebuttals.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News